Drugs & Targets FDA grants Breakthrough Therapy Designation to epcoritamab-bysp December 01, 2023Vol.49 No.44
Drugs & Targets FDA approves Keytruda + chemo for HER2-negative gastric or GEJ cancer November 17, 2023Vol.49 No.43
Drugs & Targets FDA approves Edison histotripsy device to treat liver tumors November 17, 2023Vol.49 No.43
Drugs & Targets CHMP issues positive opinion Keytruda + chemo as first-line treatment for metastatic biliary tract cancer November 17, 2023Vol.49 No.43
Drugs & Targets Legend Biotech, Novartis partner to advance SCLC research November 17, 2023Vol.49 No.43
Drugs & Targets FDA approves Fruzaqla for previously treated metastatic CRC November 10, 2023Vol.49 No.42
Drugs & Targets Cancer Research UK, KWF Dutch Cancer Society enter partnership to bring drugs into clinical development November 10, 2023Vol.49 No.42
